Home Ingredients Niagen® (Nicotinamide Riboside — ChromaDex)
AntioxidantCognitiveEnergy

Niagen® (Nicotinamide Riboside — ChromaDex)

Evidence Level
Strong
3 Clinical Trials
7 Documented Benefits
4/5 Evidence Score

Niagen® is the branded nicotinamide riboside (NR) from ChromaDex — essentially the only commercially viable NR product with reliable manufacturing capability at scale. Patented synthesis process and dedicated clinical research program documenting the safety and bioavailability of NR specifically. Niagen® is used in essentially every published clinical trial of NR supplementation, including the foundational trials documenting blood NAD+ elevation in humans. FDA New Dietary Ingredient (NDI) notification accepted and Generally Recognized as Safe (GRAS) status established. Standardized to ≥98% purity with reproducible manufacturing. The honest framing: the brand premium has stronger justification than most supplements because Niagen® is essentially the only NR form clinical research has validated and the only one with reliable commercial-scale manufacturing. Generic alternatives carry meaningful uncertainty about actual NR content and stability. Long-term real-world health benefits remain less well-established than the immediate NAD+ biomarker effects.

Studied Dose Clinical trial doses: 250-1,000 mg/day Niagen®. Most studies use 300-600 mg/day. Take with or without food. Long-term safety established up to 1,000 mg/day for 60+ days in clinical trials.
Active Compound Niagen® nicotinamide riboside chloride (ChromaDex). Patented synthesis process; standardized to ≥98% purity. FDA NDI accepted, GRAS status established.

Benefits

Foundational blood NAD+ elevation evidence

The foundational clinical evidence for NR supplementation raising blood NAD+ levels used Niagen® specifically. Multiple trials document 40-50% NAD+ elevation at standard doses within 2-4 weeks. Niagen® is the form the published evidence validates.

Supported by Trial 1

Cardiovascular trial evidence

Niagen® supplementation in older adults with stage 1 hypertension showed modest reductions in blood pressure and improvements in arterial stiffness. The cardiovascular biomarker evidence supports the broader healthy-aging positioning at the trial level.

Supported by Trial 2

Patent-protected manufacturing process

ChromaDex's patented Niagen® manufacturing produces stable NR with reproducible purity (≥98%). The manufacturing complexity is non-trivial — generic NR products often have stability problems or lower actual NR content than labels claim. Niagen® addresses this through quality control.

Supported by Trial 1

FDA NDI and GRAS status

Niagen® has FDA New Dietary Ingredient (NDI) notification accepted and GRAS status established. Important regulatory credentials supporting clinical-grade use in supplement formulations and demonstrating commitment to safety documentation.

Supported by Trial 3, Trial 1

Commercial-scale supply reliability

ChromaDex is essentially the only NR manufacturer with reliable commercial-scale supply. Most quality NR supplements on the market use Niagen® for this reason. Generic alternatives often have supply chain instability or quality control inconsistencies.

Supported by Trial 1, Trial 2

Clinical safety documentation

Long-term Niagen® safety established up to 1,000 mg/day for 60+ days in clinical trials. Documented well-tolerated profile with side effects at rates comparable to placebo. Important safety credentials supporting long-term supplementation use.

Supported by Trial 3

Research collaboration program

ChromaDex actively partners with academic researchers and runs ongoing clinical trial programs. The dedicated research program produces continued clinical evidence specific to Niagen® rather than relying on extrapolation from generic NR studies.

Supported by Trial 1, Trial 3

Mechanism of action

1

Direct NAD+ precursor pathway

Niagen® NR is phosphorylated to nicotinamide mononucleotide (NMN), then converted to NAD+ through the cell's normal NAD+ biosynthesis pathway. Provides a direct precursor approach that efficiently elevates intracellular NAD+ levels.

2

Stable manufacturing and bioavailability

Patented manufacturing produces stable NR that survives stomach acid and intestinal absorption. Distinguishes from generic NR products that may degrade during shelf storage or have inconsistent bioavailability.

3

Sirtuin and PARP enzyme support via NAD+

Elevated NAD+ from Niagen® supplementation supports sirtuin enzyme activity (longevity pathways) and PARP enzyme activity (DNA repair). Mechanism foundation for the aging-related claims, though clinical translation to longevity outcomes remains uncertain.

Clinical trials

1
Blood NAD+ elevation trials

Multiple clinical trials in healthy adults document Niagen® supplementation raises blood NAD+ levels 40-50% at 250-1,000 mg/day doses within 2-4 weeks. The most consistent and well-documented biomarker effect for any NAD+ precursor supplement.

2
Cardiovascular trial in older adults

A trial in older adults with stage 1 hypertension showed Niagen® modestly reduced blood pressure and improved arterial stiffness over 6 weeks. Suggests cardiovascular benefits aligned with the broader NAD+/healthy aging hypothesis.

3
Safety and tolerability studies

Long-term safety studies up to 1,000 mg/day for 60+ days show Niagen® is well-tolerated with side effects at rates comparable to placebo. Supports use as long-term supplementation strategy.

Side effects and drug interactions

Common Potential side effects

GENERALLY WELL-TOLERATED at typical doses.
Mild GI discomfort, flushing, or headache possible in some users.
Long-term safety data is reassuring but limited to 60+ day clinical trials.
Pregnant and lactating women should consult healthcare providers — limited specific safety data.
No significant cardiovascular concerns documented in trials.

Important Drug interactions

Generally minimal drug interactions documented.
Theoretical caution with medications affecting NAD+ metabolism (some chemotherapy).
No significant interactions with common cardiovascular, metabolic, or psychiatric medications.
Consult healthcare providers when combining with prescription medications, particularly cancer therapies.

More Antioxidant Ingredients

Immune Support
Vitamin C
Vitamin C, also known as ascorbic acid, is a water-soluble vitamin commonly used in supple…
Immune Support
Zinc
Zinc, an essential trace mineral, is commonly supplemented in forms like zinc gluconate, a…
Immune Support
Vitamin A
Vitamin A is a fat-soluble nutrient essential for vision, immune function, and cellular gr…
Bone Health
Copper
Copper is an essential trace mineral and cofactor for over 30 enzymatic reactions, includi…

Frequently asked questions about Niagen® (Nicotinamide Riboside — ChromaDex)

What is Niagen® (Nicotinamide Riboside — ChromaDex)?

Niagen® is the branded nicotinamide riboside (NR) from ChromaDex — essentially the only commercially viable NR product with reliable manufacturing capability at scale.

What does Niagen® (Nicotinamide Riboside — ChromaDex) do?

Niagen® NR is phosphorylated to nicotinamide mononucleotide (NMN), then converted to NAD+ through the cell's normal NAD+ biosynthesis pathway. Provides a direct precursor approach that efficiently elevates intracellular NAD+ levels. In clinical research, Niagen® (Nicotinamide Riboside — ChromaDex) has been studied for foundational blood nad+ elevation evidence, cardiovascular trial evidence, patent-protected manufacturing process.

Who should take Niagen® (Nicotinamide Riboside — ChromaDex)?

Niagen® (Nicotinamide Riboside — ChromaDex) may be most relevant for people interested in antioxidant, cognitive, energy. It has been clinically studied for foundational blood nad+ elevation evidence, cardiovascular trial evidence, patent-protected manufacturing process. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Niagen® (Nicotinamide Riboside — ChromaDex) take to work?

In clinical trials, effects have been measured at 4 weeks of consistent use. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Niagen® (Nicotinamide Riboside — ChromaDex)?

For anti-inflammatory and joint goals, Niagen® (Nicotinamide Riboside — ChromaDex) is typically taken with meals — fat-containing food often improves absorption for fat-soluble compounds. Daily consistency matters more than precise timing for cumulative anti-inflammatory effects. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Niagen® (Nicotinamide Riboside — ChromaDex) worth taking?

Niagen® (Nicotinamide Riboside — ChromaDex) has strong clinical evidence (Evidence Level 4/5 on NutraSmarts) for its primary uses, with multiple randomized controlled trials and meta-analyses supporting its benefits. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Niagen® (Nicotinamide Riboside — ChromaDex) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Niagen® (Nicotinamide Riboside — ChromaDex)?

The clinically studied dose for Niagen® (Nicotinamide Riboside — ChromaDex) is Clinical trial doses: 250-1,000 mg/day Niagen®. Most studies use 300-600 mg/day. Take with or without food. Long-term safety established up to 1,000 mg/day for 60+ days in clinical trials.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Niagen® (Nicotinamide Riboside — ChromaDex) used for?

Niagen® (Nicotinamide Riboside — ChromaDex) is studied for foundational blood nad+ elevation evidence, cardiovascular trial evidence, patent-protected manufacturing process. The foundational clinical evidence for NR supplementation raising blood NAD+ levels used Niagen® specifically. Multiple trials document 40-50% NAD+ elevation at standard doses within 2-4 weeks. Niagen® is the form the published evidence validates.